The COVID-19 vaccines developed for the 2024-2025 respiratory disease season were around 75% effective at preventing ...
Results showed that vaccination reduced the risk of preterm birth by 20% during the Delta wave of the COVID pandemic and 36% ...
Pfizer's COVID-19 vaccine has become the first in the U.S. to receive full approval from the FDA for people ages 16 and up.
Pregnant people who receive a COVID vaccine are 60 percent less likely to experience severe disease and around 30 percent ...
The Defense Department plans to review the records of thousands of service members who were discharged for refusing to take ...
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
Pfizer CEO Albert Bourla defended his company’s vaccine business as rhetoric from HHS Secretary Robert F. Kennedy Jr. drives ...
Pfizer's profits will fall short of Wall Street estimates next year, as it faces weaker sales of COVID products and squeezed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback